Latest filing published 26 Dec 2017 for Rockwell Medical, INC., €1.4M.
Insider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -41.4%Entry US$1,390.40 · Close at T+365 US$815.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert L. Chioini: trading record in brief
Robert L. Chioini discloses dealings in Rockwell Medical, Inc. to SEC (Form 4). Between 13 July 2007 and 15 December 2017, the trades on record add up to 56 filings.
The open-market side counts 4 purchases for €105k alongside 19 sales for €795k. The net balance comes to €689k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 20 share grants and 11 option exercises.
Half of the purchases are above €25k and half below. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -19.3%. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 26 December 2017: an option exercise of €1.4M, in Rockwell Medical, Inc. The most recent open-market purchase was published on 14 August 2015, 4,104 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert L. Chioini
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 250,000 shares@ US$6.5019.4% of flowCommon StockSEC:0001209191-17-067258:0
- 245,076 shares@ US$6.6019.3% of flowCommon StockSEC:0001209191-17-067258:1
- 325,000 shares@ US$6.5025.2% of flowCommon StockSEC:0001209191-17-066455:0
- 320,076 shares@ US$6.6025.2% of flowCommon StockSEC:0001209191-17-066455:1
- 118,950 shares@ US$7.2010.8% of flowCommon StockSEC:0001209191-17-041688:0
- 200,000 shares0Common StockSEC:0001209191-17-022661:0
- 45,000 shares0Common StockSEC:0001209191-17-022661:1
- 375,000 shares@ US$4.55Common StockSEC:0001209191-15-085359:0
- 75,000 shares@ US$9.33Common StockSEC:0001209191-15-085359:1
- 200,000 shares0Common StockSEC:0001209191-15-074463:0
- 125,000 shares0Common StockSEC:0001209191-15-074463:1
- 2,900 shares@ US$11.50Common StockSEC:0001209191-15-065959:0Canonical exit: 11 Nov 2015 (T+90)
- 300 shares@ US$11.52Common StockSEC:0001209191-15-065959:1Canonical exit: 11 Nov 2015 (T+90)
- 1,890 shares@ US$11.53Common StockSEC:0001209191-15-065959:2Canonical exit: 11 Nov 2015 (T+90)
- 4,910 shares@ US$11.96Common StockSEC:0001209191-15-066050:0Canonical exit: 12 Nov 2015 (T+90)
- 73,200 shares@ US$9.64Common StockSEC:0001209191-15-038912:0
- 46,200 shares@ US$10.47Common StockSEC:0001209191-15-021377:0
- 335,000 shares@ US$2.79Common StockSEC:0001209191-14-077716:0
- 260,000 shares@ US$8.56Common StockSEC:0001209191-14-077716:1
- 200,000 shares0Common StockSEC:0001209191-14-061919:0
- 100,000 shares0Common StockSEC:0001209191-14-003352:0
- 105,000 shares@ US$4.05Common StockSEC:0001209191-14-002498:0
- 300,000 shares@ US$1.81Common StockSEC:0001209191-13-033171:0
- 58,000 shares@ US$4.12Common StockSEC:0001209191-13-033171:1
- 100,000 shares0Common StockSEC:0001209191-13-032679:0
25 of 55 declarations
